BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19255944)

  • 1. NRF2 Serves a Critical Role in Regulation of Immune Checkpoint Proteins (ICPs) During Trophoblast Differentiation.
    Hong K; Muralimanoharan S; Kwak YT; Mendelson CR
    Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35596653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C/EBPbeta (NF-M) is essential for activation of the p20K lipocalin gene in growth-arrested chicken embryo fibroblasts.
    Kim S; Mao PL; Gagliardi M; Bédard PA
    Mol Cell Biol; 1999 Aug; 19(8):5718-31. PubMed ID: 10409760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RPA1 binding to NRF2 switches ARE-dependent transcriptional activation to ARE-NRE-dependent repression.
    Liu P; Rojo de la Vega M; Sammani S; Mascarenhas JB; Kerins M; Dodson M; Sun X; Wang T; Ooi A; Garcia JGN; Zhang DD
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10352-E10361. PubMed ID: 30309964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic analysis of brain tissues identifies a role for CCAAT enhancer binding protein β in HIV-associated neurocognitive disorder.
    Canchi S; Swinton MK; Rissman RA; Fields JA
    J Neuroinflammation; 2020 Apr; 17(1):112. PubMed ID: 32276639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver.
    Kitteringham NR; Abdullah A; Walsh J; Randle L; Jenkins RE; Sison R; Goldring CE; Powell H; Sanderson C; Williams S; Higgins L; Yamamoto M; Hayes J; Park BK
    J Proteomics; 2010 Jun; 73(8):1612-31. PubMed ID: 20399915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic imbalance (AI) identifies novel tissue-specific cis-regulatory variation for human UGT2B15.
    Sun C; Southard C; Witonsky DB; Olopade OI; Di Rienzo A
    Hum Mutat; 2010 Jan; 31(1):99-107. PubMed ID: 19847790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The winding road toward transcriptional repression.
    Zhang Q; Brand M
    Mol Cell; 2023 Mar; 83(5):653-654. PubMed ID: 36868186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences.
    Boulahtouf Z; Virzì A; Baumert TF; Verrier ER; Lupberger J
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hepatitis B Virus Interactome: A Comprehensive Overview.
    Van Damme E; Vanhove J; Severyn B; Verschueren L; Pauwels F
    Front Microbiol; 2021; 12():724877. PubMed ID: 34603251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Glutathione Content in Liver Diseases: An Update.
    Vairetti M; Di Pasqua LG; Cagna M; Richelmi P; Ferrigno A; Berardo C
    Antioxidants (Basel); 2021 Feb; 10(3):. PubMed ID: 33670839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis.
    Bender D; Hildt E
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis.
    Ivanov AV; Valuev-Elliston VT; Tyurina DA; Ivanova ON; Kochetkov SN; Bartosch B; Isaguliants MG
    Oncotarget; 2017 Jan; 8(3):3895-3932. PubMed ID: 27965466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses.
    Komaravelli N; Casola A
    J Pharmacogenomics Pharmacoproteomics; 2014 Sep; 5(4):. PubMed ID: 25584194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transactivation of genes encoding for phase II enzymes and phase III transporters by phytochemical antioxidants.
    Yang YM; Noh K; Han CY; Kim SG
    Molecules; 2010 Sep; 15(9):6332-48. PubMed ID: 20877225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
    Cho IJ; Ki SH; Brooks C; Kim SG
    Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide, an apoptotic rheostat, inhibits CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 activation: the role in glutathione S-transferase A2 gene repression.
    Park IN; Cho IJ; Kim SG
    Drug Metab Dispos; 2004 Sep; 32(9):893-7. PubMed ID: 15319326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
    Ki SH; Cho IJ; Choi DW; Kim SG
    Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the oxidized metabolites of oltipraz on the activation of CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 for GSTA2 gene induction.
    Ko MS; Lee SJ; Kim JW; Lim JW; Kim SG
    Drug Metab Dispos; 2006 Aug; 34(8):1353-60. PubMed ID: 16714377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 as a novel molecular target for chemoprevention.
    Lee JS; Surh YJ
    Cancer Lett; 2005 Jun; 224(2):171-84. PubMed ID: 15914268
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.